Company Overview and News

 
TLR / Timberline Resources Corporation TIMBERLINE RESOURCES, INC. FORM 8-K (Current Report)

2018-09-10 sec.gov
Timberline Resources Corp UNITED STATES SECURITIES AND EXCHANGE COMMISSION
TLR

1
Timberline Resources Announces Management Change

2018-09-10 accesswire
COEUR D'ALENE, ID / ACCESSWIRE / September 10, 2018 /Timberline Resources Corporation (OTCQB: TLRS; TSX-V: TBR) ("Timberline" or the "Company") is pleased to announce the appointment of Mr. Ted Sharp as Chief Financial Officer (CFO) for the Company.
KTEC ABX MUX.RTWI MUX TLRS TLR MUX ABX

 
TLR / Timberline Resources Corporation null (Current Report)

2018-08-29 sec.gov
Timberline Resources Corp. UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549
TLR

1
Timberline Commences Drilling at Elder Creek, Gravity Survey at Eureka, and Announces Management Changes

2018-08-29 accesswire
COEUR D'ALENE, ID / ACCESSWIRE / August 29, 2018 / Timberline Resources Corporation (OTCQB: TLRS; TSX-V: TBR) ("Timberline" or the "Company") is pleased to announce that exploration drilling has begun at its Elder Creek porphyry copper-gold project in the Battle Mountain Mining District of Nevada. The Company will also conduct a district-scale gravity survey on its Eureka project and will target high-grade gold mineralization at depth in the Lookout Mountain area.
APPPF ABX MUX.RTWI CCCCF MUX TLRS TLR MUX ABX CCC

 
TLR / Timberline Resources Corporation TIMBERLINE RESOURCES, INC. FORM 8-K (Current Report)

2018-08-16 sec.gov
Timberline Resources Corp UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549
TLR

1
Timberline Resources Closes Acquisition of Battle Mountain Gold-Copper Property Interests and Announces Exploration Program

2018-08-14 accesswire
COEUR D'ALENE, ID / ACCESSWIRE / August 14, 2018 / Timberline Resources Corporation (OTCQB: TLR; TSX-V: TBR) ("Timberline" or the "Company") announced today that it has closed on the acquisition of ownership interests in two Nevada gold-copper mineral properties located in the Battle Mountain mining district in Nevada (the "Properties") from Americas Gold Exploration, Inc. ("AGEI"). The acquisition includes the right to earn into existing joint venture agreements with McEwen Mining Inc.
ABX MUX.RTWI MUX TLRS TLR MUX ABX

 
TLR / Timberline Resources Corporation TIMBERLINE RESOURCES, INC. FORM 8-K (Current Report)

2018-08-13 sec.gov
Timberline Resources Corp UNITED STATES SECURITIES AND EXCHANGE COMMISSION
TLR

 
Timberline Announces Third Quarter 2018 Financial Results

2018-08-13 accesswire
COEUR D'ALENE, ID / ACCESSWIRE / August 13, 2018 / Timberline Resources Corporation (OTCQB: TLRS; TSX-V: TBR) ("Timberline" or the "Company") today announced consolidated financial results for its second fiscal year 2018 quarter which ended June 30, 2018. A summary of selected financial results is presented in the following table:
TLRS TLR

 
TLR / Timberline Resources Corporation TIMBERLINE RESOURCES CORP FORM 10-Q (Quarterly Report)

2018-08-13 sec.gov
Timberline Resources Corp. UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM
TLR

1
Timberline Resources Announces High-Grade Gold Assay Results from the Windfall Project at its Eureka Property, Nevada

2018-08-08 accesswire
COEUR D'ALENE, ID / ACCESSWIRE / August 8, 2018 / Timberline Resources Corporation (OTCQB: TLRS; TSX-V: TBR) ("Timberline" or the "Company") announced today that recently completed rock chip sampling (Table 1) confirms high-grade gold mineralization within the historic Windfall Mine area of the 23 square-mile Eureka property in Nevada (Figure 1). The Windfall Mine open pit is centrally located on the Windfall trend, a zone which extends 1.
ABX MUX.RTWI MUX TLRS TLR MUX ABX

 
TLR / Timberline Resources Corporation TIMBERLINE RESOURCES, INC. FORM 8-K (Current Report)

2018-08-02 sec.gov
Timberline Resources Corp. UNITED STATES SECURITIES AND EXCHANGE COMMISSION
TLR

1
Timberline Resources Announces Loan Agreement

2018-07-30 accesswire
COEUR D'ALENE, ID / ACCESSWIRE / July 30, 2018 / Timberline Resources Corporation (OTCQB: TLRS; TSX-V: TBR) ("Timberline" or the "Company") announced today that it proposes to enter into a loan agreement (the "Loan Agreement") with William Matlack (the "Lender"). Under the Loan Agreement, the Lender will loan to Timberline up to US$300,000 (the "Principal Sum"), with the Principal Sum bearing interest at an annual rate of 18%, compounded monthly.
ABX MUX.RTWI MUX TLRS TLR MUX ABX

 
TLR / Timberline Resources Corporation TIMBERLINE RESOURCES, INC. FORM 8-K (Current Report)

2018-07-24 sec.gov
Timberline Resources Corp. UNITED STATES SECURITIES AND EXCHANGE COMMISSION
TLR

1
Timberline Resources Provides Exploration Update on Windfall and Lookout Mountain Projects at Its Eureka Property in Nevada

2018-07-10 accesswire
COUER D'ALENE, ID / ACCESSWIRE / July 10, 2018 / Timberline Resources Corporation (OTCQB: TLRS; TSX-V: TBR) ("Timberline" or the "Company") announces an exploration update on its 23-square mile Eureka property (Figure 1) in Nevada's prolific Battle Mountain - Eureka gold trend. At the Windfall project, Timberline's exploration is focused on additional drilling to support development of an initial open-pittable oxide resource estimate.
ABX MUX.RTWI MUX MALRY TLRS TLR MALRF MUX MIN ABX

3
TLR / Timberline Resources Corporation TIMBERLINE RESOURCES, INC. FORM 8-K (Current Report)

2018-06-27 sec.gov
Timberline Resources Corp. UNITED STATES SECURITIES AND EXCHANGE COMMISSION
TLR

Related Articles

RIGL: Rigel Pharmaceuticals Analysis and Research Report

2018-09-18 - Asif

Overview Rigel Pharmaceuticals is a biotechnology company dedicated to discovering, developing and providing novel small molecule drugs that significantly improve the lives of patients with immune and hematologic disorders, cancer and rare diseases. The company's pioneering research focuses on signaling pathways that are critical to disease mechanisms. The company's first FDA-approved product is TAVALISSE™ (fostamatinib disodium hexahydrate), an oral spleen tyrosine kinase (SYK) inhibitor, for the treatment of adult patients with chronic immune thrombocytopenia who have had an insufficient response to a previous treatment. The company's current clinical programs include Phase 2 studies of fostamatinib in autoimmune hemolytic anemia and IgA nephropathy, and a Phase 1 study for its IRAK program. In addition, Rigel Pharmaceuticals has product candidates in development with partners BerGenBio AS, Daiichi Sankyo, and Aclaris Therapeutics. Since inception, Rigel Pharmaceuticals h...

EKSO: Ekso Bionics Holdings Analysis and Research Report

2018-09-18 - Asif

Overview The company design, develop and sell exoskeleton technology to augment human strength, endurance and mobility. The company's exoskeleton technology serves multiple markets and can be used both by able-bodied users as well as by persons with physical disabilities. Ekso Bionics has sold, rented or leased devices that (a) enable individuals with neurological conditions affecting gait (stroke and spinal cord injury) to rehabilitate and to walk again and (b) allow industrial workers to perform heavy duty work for extended periods. Today, its medical exoskeleton, Ekso GT, is used as a rehabilitation tool to allow physicians and therapists to rehabilitate patients who have suffered a stroke or spinal cord injury. With its unique features designed specifically for hospitals and its proprietary SmartAssist software, Ekso GT allows for the early mobilization of patients, with high step count and high dosage treatments. The intent is to allow the patient’s central nervous syst...

AGRX: Agile Therapeutics Analysis and Research Report

2018-09-18 - Asif

Overview Agile Therapeutics is a forward-thinking women’s healthcare company dedicated to fulfilling the unmet health needs of today’s women. Twirla® and its other current potential product candidates are designed to provide women with contraceptive options that offer greater convenience and facilitate compliance. The company's lead product candidate, Twirla, also known as AG200-15, is a once-weekly prescription contraceptive patch that is at the end of Phase 3 clinical development. Since its inception in 1997, Agile Therapeutics has devoted substantial resources to developing Twirla, building its intellectual property portfolio, business planning, raising capital and providing general and administrative support for these operations. The company incurred research and development expenses of $14.4 million, $20.9 million and $25.6 million during the years ended December 31, 2017, 2016 and 2015, respectively. The company incurred research and development expenses of $2.4 milli...

Silicon Investor Message Boards

This table lists all message boards related to TLR / Timberline Resources Corporation on message board site Silicon Investor.

Timberline Resources Timberline Resources Timberline Resources Tularik Inc. (TLRK) Tularik Inc. (TLRK) Tularik Inc. (TLRK)
TolerRx (TLRX) TolerRx (TLRX) TolerRx (TLRX) Tri-Link Resources Tri-Link Resources Tri-Link Resources
CUSIP: 887133106